LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 44.42 | 17.25 | 8 | 3895 | 0.0021 | -0.0936 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 44.42 | 17.25 | 4458 | 3895 | 1.1443 | 1.0348 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 46.39 | 17.25 | 1278 | 4141 | 0.3086 | 0.7237 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 46.39 | 17.25 | 5359 | 4141 | 1.2940 | 1.0663 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 46.39 | 17.25 | 12 | 4141 | 0.0029 | -0.0449 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 46.39 | 17.25 | 4746 | 4141 | 1.1459 | 1.0348 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 48.36 | 17.25 | 1082 | 4390 | 0.2465 | 0.6785 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 48.36 | 17.25 | 5731 | 4390 | 1.3054 | 1.0678 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 48.36 | 17.25 | 8 | 4390 | 0.0018 | -0.0917 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 48.36 | 17.25 | 5046 | 4390 | 1.1493 | 1.0351 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 50.33 | 17.25 | 878 | 4651 | 0.1888 | 0.6269 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 50.33 | 17.25 | 6021 | 4651 | 1.2945 | 1.0650 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 50.33 | 17.25 | 6 | 4651 | 0.0013 | -0.1226 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 50.33 | 17.25 | 5435 | 4651 | 1.1685 | 1.0390 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 52.30 | 17.25 | 680 | 4798 | 0.1417 | 0.5722 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 52.30 | 17.25 | 6434 | 4798 | 1.3408 | 1.0736 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 52.30 | 17.25 | 17 | 4798 | 0.0035 | -0.0018 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 52.30 | 17.25 | 5896 | 4798 | 1.2287 | 1.0514 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 54.27 | 17.25 | 1102 | 4884 | 0.2256 | 0.6659 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 54.27 | 17.25 | 6988 | 4884 | 1.4308 | 1.0899 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 54.27 | 17.25 | 36 | 4884 | 0.0074 | 0.0945 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 54.27 | 17.25 | 6364 | 4884 | 1.3030 | 1.0661 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 56.24 | 17.25 | 476 | 4929 | 0.0966 | 0.5018 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 56.24 | 17.25 | 7524 | 4929 | 1.5265 | 1.1064 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 56.24 | 17.25 | 14 | 4929 | 0.0028 | -0.0253 | MN20160310_N02 | K13 |